2012
DOI: 10.1371/journal.pone.0049581
|View full text |Cite
|
Sign up to set email alerts
|

The Transcription Factor GLI1 Mediates TGFβ1 Driven EMT in Hepatocellular Carcinoma via a SNAI1-Dependent Mechanism

Abstract: The role of the epithelial-to-mesenchymal transition (EMT) during hepatocellular carcinoma (HCC) progression is well established, however the regulatory mechanisms modulating this phenomenon remain unclear. Here, we demonstrate that transcription factor glioma-associated oncogene 1 (GLI1) modulates EMT through direct up-regulation of SNAI1 and serves as a downstream effector of the transforming growth factor-β1 (TGFβ1) pathway, a well-known regulator of EMT in cancer cells. Overexpression of GLI1 increased pro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
60
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 69 publications
(62 citation statements)
references
References 38 publications
2
60
0
Order By: Relevance
“…The caspase 3/7 activity assay was conducted using an Apo-ONE® Homogeneous Caspase-3/7 Assay (Promega, Madison, WI, USA), as described in our previous study [28]. …”
Section: Methodsmentioning
confidence: 99%
“…The caspase 3/7 activity assay was conducted using an Apo-ONE® Homogeneous Caspase-3/7 Assay (Promega, Madison, WI, USA), as described in our previous study [28]. …”
Section: Methodsmentioning
confidence: 99%
“…cDNA synthesis and qRT-PCR analysis were done as described. 37 The ABI TaqMan probes (Applied Biosystems, Carlsbad, CA, USA) targeting PCAF (Hs00187332_m1) and 18 s rRNA (Hs99999901_s1) were used here. The relative expression of PCAF was shown as fold difference relative to 18 s rRNA.…”
Section: Methodsmentioning
confidence: 99%
“…The protocol for western immunoblotting has been described in our previous paper [12]. Briefly, cell lysates were prepared in RIPA buffer with inhibitors of proteases and with sodium orthovanadate as an inhibitor of phosphotases.…”
Section: Methodsmentioning
confidence: 99%